Pediatric and Congenital Electrophysiology Society (PACES), Heart Rhythm Society (HRS), American College of Cardiology Foundation (ACCF), et al. PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff- Parkinson-White (WPW, ventricular preexcitation) electrocardio- graphic pattern. Developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS) Heart Rhythm. 2012;9:1006 24. 4.3.5. Tetralogy of Fallot S4.3.5-1. Knauth AL, Gauvreau K, Powell AJ, et al. Ventricular size and func- tion assessed by cardiac MRI predict major adverse clinical out- comes late after tetralogy of Fallot repair. Heart. 2008;94:211 6. S4.3.5-2. Morray BH, McElhinney DB, Cheatham JP, et al. Risk of coronary ar- tery compression among patients referred for transcatheter pulmo- nary valve implantation: a multicenter experience. Circ Cardiovasc Interv. 2013;6:535 42. S4.3.5-3. Khairy P, Van Hare GF, Balaji S, et al. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease. Developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS) Heart Rhythm. 2014;11:e102 65. S4.3.5-4. Dietl CA, Cazzaniga ME, Dubner SJ, et al. Life-threatening arrhyth- mias and RV dysfunction after surgical repair of tetralogy of Fallot. Comparison between transventricular and transatrial approaches. Circulation. 1994;90:II7 12. S4.3.5-5. Khairy P, Landzberg MJ, Gatzoulis MA, et al. Value of programmed ventricular stimulation after tetralogy of Fallot repair: a multicenter study. Circulation. 2004;109:1994 2000. S4.3.5-6. Tsai SF, Chan DP, Ro PS, et al. Rate of inducible ventricular ar- rhythmia in adults with congenital heart disease. Am J Cardiol. 2010;106:730 6. S4.3.5-7. Khairy P. Programmed ventricular stimulation for risk stratification in patients with tetralogy of Fallot: a Bayesian perspective. Nat Clin Pract Cardiovasc Med. 2007;4:292 3. CLINICAL STATEMENTS AND GUIDELINES S4.3.5-8. Lucron H, Mar on F, Bosser G, et al. 